The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Emerging roles of proteases in tumour suppression
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mariño, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N., & López-Otín, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701194200 · Cited by 407
Self-citationRetractedMariño, G., Urı́a, J. A., Puente, X. S., Quesada, V., Bordallo, J., & López-Otı́n, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208247200 · Cited by 208
Self-citationRetractedNew functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Self-citationTargeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Self-citationMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
Brummelkamp, T. R., Nijman, S. M. B., Dirac, A. M. G., & Bernards, R. (2003) · Nature · doi:10.1038/nature01811 · Cited by 952
Human and mouse proteases: a comparative genomic approach
Puente, X. S., Sánchez, L. M., Overall, C. M., & López-Otín, C. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1111 · Cited by 943
Self-citationThe Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
PORTER, S., CLARK, I. M., KEVORKIAN, L., & EDWARDS, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20040424 · Cited by 779
Levine, B. (2007) · Nature · doi:10.1038/446745a · Cited by 741
Identification of the familial cylindromatosis tumour-suppressor gene
Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R., et al. (2000) · Nature Genetics · doi:10.1038/76006 · Cited by 666
Protease degradomics: A new challenge for proteomics
López-Otín, C., & Overall, C. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm858 · Cited by 664
Self-citationThe emerging roles of human tissue kallikreins in cancer
Borgoño, C. A., & Diamandis, E. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1474 · Cited by 650
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
Loss of collagenase-2 confers increased skin tumor susceptibility to male mice
Balbín, M., Fueyo, A., Tester, A. M., Pendás, A. M., Pitiot, A. S., Astudillo, A., Overall, C. M., Shapiro, S. D., & López-Otín, C. (2003) · Nature Genetics · doi:10.1038/ng1249 · Cited by 536
Self-citationDong, Z., Kumar, R., Yang, X., & Fidler, I. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81926-1 · Cited by 525
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., & Fässler, R. (2006) · Cell · doi:10.1016/j.cell.2006.03.041 · Cited by 476
Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
Varela, I., Cadiñanos, J., Pendás, A. M., Gutiérrez-Fernández, A., Folgueras, A. R., Sánchez, L. M., Zhou, Z., Rodríguez, F. J., Stewart, C. L., Vega, J. A., et al. (2005) · Nature · doi:10.1038/nature04019 · Cited by 466
Self-citationUbiquitin and ubiquitin-like proteins in cancer pathogenesis
Hoeller, D., Hecker, C.-M., & Dikic, I. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1994 · Cited by 408
A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Hepsin promotes prostate cancer progression and metastasis
Klezovitch, O., Chevillet, J., Mirosevich, J., Roberts, R. L., Matusik, R. J., & Vasioukhin, V. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.008 · Cited by 282
Potentiation of neuroblastoma metastasis by loss of caspase-8
Stupack, D. G., Teitz, T., Potter, M. D., Mikolon, D., Houghton, P. J., Kidd, V. J., Lahti, J. M., & Cheresh, D. A. (2006) · Nature · doi:10.1038/nature04323 · Cited by 277
Enzyme replacement and enhancement therapies: lessons from lysosomal disorders
Desnick, R. J., & Schuchman, E. H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg963 · Cited by 268
ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165
Luque, A., Carpizo, D. R., & Iruela-Arispe, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212964200 · Cited by 263
Scorilas, A., Karameris, A., Arnogiannaki, N., Ardavanis, A., Bassilopoulos, P., Trangas, T., & Talieri, M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1810 · Cited by 258
Dysregulated Expression of Adamalysin-Thrombospondin Genes in Human Breast Carcinoma
Porter, S., Scott, S. D., Sassoon, E. M., Williams, M. R., Jones, J. L., Girling, A. C., Ball, R. Y., & Edwards, D. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0398-3 · Cited by 246
ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2
Lee, N. V., Sato, M., Annis, D. S., Loo, J. A., Wu, L., Mosher, D. F., & Iruela‐Arispe, M. L. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601400 · Cited by 211
Uría, J. A., & López-Otín, C. (2000) · PubMed · Cited by 206
Self-citationDeregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.
Harada, K., Toyooka, S., Shivapurkar, N., Maitra, A., Reddy, J., Matta, H., Miyajima, K., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., et al. (2002) · PubMed · Cited by 193
A Genomic Analysis of Rat Proteases and Protease Inhibitors
Puente, X. S., & López-Otín, C. (2004) · Genome Research · doi:10.1101/gr.1946304 · Cited by 192
Self-citationA Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
Wesley, U. V., Albino, A. P., Tiwari, S., & Houghton, A. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.311 · Cited by 190
Carcinogen exposure and gene promoter hypermethylation in bladder cancer
Marsit, C. J., Karagas, M. R., Danaee, H., Liu, M., Andrew, A., Schned, A., Nelson, H. H., & Kelsey, K. T. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi172 · Cited by 189
Killian, C. S., Corral, D. A., Kawinski, E., & Constantine, R. I. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1506 · Cited by 178
Macrophage Elastase (Matrix Metalloproteinase-12) Suppresses Growth of Lung Metastases
Houghton, A. M., Grisolano, J. L., Baumann, M. L., Kobayashi, D. K., Hautamaki, R. D., Nehring, L. C., Cornelius, L. A., & Shapiro, S. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-0297 · Cited by 178
CASPASE-8 Gene Is Inactivated by Somatic Mutations in Gastric Carcinomas
Soung, Y. H., Lee, J. W., Kim, S. Y., Jang, J., Park, Y. G., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2005) · Cancer Research · doi:10.1158/0008-5472.815.65.3 · Cited by 176
Montel, V., Kleeman, J., Agarwal, D., Spinella, D., Kawai, K., & Tarin, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2047 · Cited by 169
Liu, Y.-J., Xu, Y., & Yu, Q. (2006) · Oncogene · doi:10.1038/sj.onc.1209287 · Cited by 167
Wesley, U. V., McGroarty, M., & Homoyouni, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1852 · Cited by 166
Reduced expression of CYLD in human colon and hepatocellular carcinomas
Hellerbrand, C., Bumes, E., Bataille, F., Dietmaier, W., Massoumi, R., & Bosserhoff, A. K. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl081 · Cited by 165
Hofmann, H., Hansen, G., Richter, G. H. S., Taege, C., Simm, A., Silber, R., & Burdach, S. E. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1086.11.3 · Cited by 161
Matrix Metalloproteinases and Tumor Progression
Freije, J. M. P., Balbín, M., Pendás, A. M., Sánchez, L. M., Puente, X. S., & López-Otín, C. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_9 · Cited by 160
Self-citationRoles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis
Kim, J. H., Choi, H. J., Kim, B., Kim, M. H., Lee, J. M., Kim, I. S., Lee, M. H., Choi, S. J., Kim, K. I., Kim, S., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1415 · Cited by 154
Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis
Pozzi, A., LeVine, W. F., & Gardner, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205045 · Cited by 154
A Protective Role for Matrix Metalloproteinase-3 in Squamous Cell Carcinoma
McCawley, L. J., Crawford, H. C., King, L. E., Mudgett, J. S., & Matrisian, L. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0910 · Cited by 148
Self-citationInactivating mutations of CASP10 gene in non-Hodgkin lymphomas
Shin, M. S., Kim, H. S., Kang, C. S., Park, W. S., Kim, S. Y., Lee, S. N., Lee, J., Park, J. Y., Jang, J. J., Kim, C. W., et al. (2002) · Blood · doi:10.1182/blood.v99.11.4094 · Cited by 142
Lind, G. E., Sahlberg, K. K., Meling, G. I., Teixeira, M. R., Thiis‐Evensen, E., Rognum, T. O., & Lothe, R. A. (2006) · Analytical Cellular Pathology · doi:10.1155/2006/949506 · Cited by 138
Novel Role of Prostate-Specific Membrane Antigen in Suppressing Prostate Cancer Invasiveness
Ghosh, A., Wang, X., Klein, E. A., & Heston, W. D. W. (2005) · Cancer Research · doi:10.1158/0008-5472.727.65.3 · Cited by 132
Somatic mutations of CASP3 gene in human cancers
Soung, Y. H., Lee, J.-W., Kim, S., Park, W.-S., Nam, S., Lee, J., Yoo, N. J., & Lee, S. (2004) · Human Genetics · doi:10.1007/s00439-004-1129-3 · Cited by 131
Overall, C. M., Tam, E. M., Kappelhoff, R., Connor, A., Ewart, T., Morrison, C. J., Puente, X. S., López-Otín, C., & Seth, A. K. (2004) · Biological Chemistry · doi:10.1515/bc.2004.058 · Cited by 130
Self-citationReinheckel, T., Hagemann, S., Dollwet-Mack, S., Martinez, E., Lohmüller, T., Zlatkovic, G., Tobin, D. J., Maas‐Szabowski, N., & Peters, C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02469 · Cited by 121
FAPα, a surface peptidase expressed during wound healing, is a tumor suppressor
Ramirez‐Montagut, T., Blachère, N. E., Sviderskaya, E. V., Bennett, D. C., Rettig, W. J., Garin‐Chesa, P., & Houghton, A. N. (2004) · Oncogene · doi:10.1038/sj.onc.1207730 · Cited by 117
Witty, J. P., Lempka, T., Coffey, R. J., & Matrisian, L. M. (1995) · PubMed · Cited by 117
Self-citationADAMTS1: A Matrix Metalloprotease with Angioinhibitory Properties
Iruela‐Arispe, M. L., Carpizo, D. R., & Luque, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03221.x · Cited by 116
Borgoño, C. A., Michael, I. P., Shaw, J. L. V., Luo, L., Ghosh, M. C., Soosaipillai, A. R., Grass, L., Katsaros, D., & Diamandis, E. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608348200 · Cited by 115
Expression of METH-1 and METH-2 in pancreatic cancer
Masui, T., Tuji, S., IDA, J., Nakajima, S., KAWAGUCHI, M., Koizumi, M., TOYODA, E., TULACHAN, S., Yasuda, S., HOSOTANI, R., et al. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)81290-7 · Cited by 113
Dunn, J. R., Reed, J. E., du Plessis, D. G., Shaw, E. J., Reeves, P., Gee, A. L., Warnke, P. C., & Walker, C. A. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603006 · Cited by 112
Pendás, A. M., Folgueras, A. R., Llano, E., Caterina, J. J., Frerard, F., Rodríguez, F. J., Astudillo, A., Noël, A., Birkedal‐Hansen, H., & López-Otín, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5304-5313.2004 · Cited by 111
Self-citationSynergy in tumor suppression by direct interaction of Neutral Endopeptidase with PTEN
Sumitomo, M., Iwase, A., Zheng, R., Navarro, D., Kaminetzky, D., Shen, R., Georgescu, M., & Nanus, D. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00331-3 · Cited by 109
Yang, W., Arii, S., Gorrín-Rivas, M. J., Mori, A. S., Onodera, H., & Imamura, M. (2001) · Cancer · doi:10.1002/1097-0142(20010401)91:7<1277::aid-cncr1129>3.0.co;2-h · Cited by 107
Involvement of neutral endopeptidase in neoplastic progression
Sumitomo, M., Shen, R., & Nanus, D. M. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.11.001 · Cited by 107
Masuya, D., Huang, C., Liu, D., Nakashima, T., Yokomise, H., Ueno, M., Nakashima, N., & Sumitomo, S. (2006) · The Journal of Pathology · doi:10.1002/path.1931 · Cited by 103
Gorrín-Rivas, M. J., Arii, S., Furutani, M., Mizumoto, M., Mori, A., Hanaki, K., Maeda, M., Furuyama, H., Kondo, Y., & Imamura, M. (2000) · PubMed · Cited by 102
Inactivating mutations of CASPASE-7 gene in human cancers
Soung, Y. H., Lee, J. W., Kim, H. S., Park, W. S., Kim, S. Y., Lee, J., Park, J. Y., Cho, Y. G., Kim, C. J., Park, Y. G., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206727 · Cited by 101
Kerkelä, E., Ala‐aho, R., Klemi, P. J., Grénman, S., Shapiro, S. D., Kähäri, V., & Saarialho‐Kere, U. (2002) · The Journal of Pathology · doi:10.1002/path.1198 · Cited by 101
Inactivating mutations of the caspase-10 gene in gastric cancer
Park, W. S., Lee, J., Shin, M. S., Park, J. Y., Kim, H. S., Lee, J. H., Kim, Y. S., Lee, S. H., Xiao, W., Park, C. H., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205394 · Cited by 93
Rocks, N., Paulissen, G., Calvo, F. Q., Polette, M., Gueders, M. M., Munaut, C., Foidart, J., Noël, A., Birembaut, P. L., & Cataldo, D. D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602990 · Cited by 93
Acuff, H. B., Sinnamon, M. J., Fingleton, B., Boone, B. E., Levy, S., Chen, X., Pozzi, A., Carbone, D. P., Schwartz, D. R., Moin, K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4279 · Cited by 92
Self-citationHEPSIN inhibits cell growth/invasion in prostate cancer cells.
Srikantan, V., Valladares, M., Rhim, J. S., Moul, J. W., & Srivastava, S. K. (2002) · PubMed · Cited by 90
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Andarawewa, K. L., Boulay, A., Masson, R., Mathelin, C., Stoll, I., Tomasetto, C., Chenard, M., Gintz, M., Bellocq, J., & Rio, M. (2003) · PubMed · Cited by 88
Karikari, C. A., Roy, I., Tryggestad, E., Feldmann, G., Pinilla, C., Welsh, K., Reed, J. C., Armour, E. P., Wong, J. W., Herman, J. M., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0634 · Cited by 87
Kuno, K., Bannai, K., Hakozaki, M., Matsushima, K., & Hirose, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.105 · Cited by 85
DiPaola, R. S., Rinehart, J. J., Nemunaitis, J. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.001 · Cited by 82
Lo, P. H. Y., Leung, A. C. C., Kwok, C. Y. C., Cheung, W. S. Y., Ko, J. M. Y., Yang, L., Law, S. Y.-K., Wang, L. D., Li, J., Stanbridge, E. J., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209767 · Cited by 80
Chen, L., & Chai, K. X. (2001) · International Journal of Cancer · doi:10.1002/ijc.1601 · Cited by 79
Takeha, S., Fujiyama, Y., Bamba, T., Sorsa, T. A., Nagura, H., & Ohtani, H. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00304.x · Cited by 76
Rce1 deficiency accelerates the development of K-RAS–induced myeloproliferative disease
Wahlstrom, A. M., Cutts, B. A., Karlsson, C., Andersson, K., Liu, M., Sjogren, A.-K. M., Swolin, B., Young, S. G., & Bergö, M. O. (2006) · Blood · doi:10.1182/blood-2006-05-024752 · Cited by 73
Molecular imaging of proteolytic activity in cancer
McIntyre, J. O., & Matrisian, L. M. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10713 · Cited by 72
Self-citationEarlier Onset of Tumoral Angiogenesis in Matrix Metalloproteinase-19–Deficient Mice
Jost, M., Folgueras, A. R., Frérart, F., Pendás, A. M., Blacher, S., Houard, X., Berndt, S., Munaut, C., Cataldo, D. D., Álvarez, J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4315 · Cited by 72
Self-citationTakada, H., Imoto, I., Tsuda, H., Nakanishi, Y., Ichikura, T., Mochizuki, H., Mitsufuji, S., Hosoda, F., Hirohashi, S., Ohki, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208952 · Cited by 71
FUNCTIONAL IMAGING OF TUMOR PROTEOLYSIS
Sloane, B. F., Sameni, M., Podgorski, I., Cavallo‐Medved, D., & Moin, K. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095853 · Cited by 67
METH-2 silencing and promoter hypermethylation in NSCLC
Dunn, J. R., Panutsopulos, D., Shaw, M. W., Heighway, J., Dormer, R., Salmo, E., Watson, S. G., Field, J. K., & Liloglou, T. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602107 · Cited by 65
Savinov, A. Y., Remacle, A. G., Golubkov, V. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3592 · Cited by 62
Gorrín-Rivas, M. J., Arii, S., Mori, A., Takeda, Y., Mizumoto, M., Furutani, M., & Imamura, M. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00010 · Cited by 59
Manton, K., Douglas, M., Netzel–Arnett, S., Fitzpatrick, D. R., Nicol, D., Boyd, A., Clements, J. A., & Antalis, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602373 · Cited by 51
Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2
Goodman, O. B., Febbraio, M., Simantov, R., Zheng, R., Shen, R., Silverstein, R. L., & Nanus, D. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602490200 · Cited by 50
Ghosh, S. K., & Duigou, G. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0581 · Cited by 43
Chen, M., Chen, L., & Chai, K. X. (2006) · The Prostate · doi:10.1002/pros.20325 · Cited by 35
Osman, I., Dai, J., Mikhail, M., Navarro, D., Taneja, S. S., Lee, P., Christos, P. J., Shen, R., & Nanus, D. M. (2006) · Cancer · doi:10.1002/cncr.22312 · Cited by 34
Offman, J., Gascoigne, K. E., Bristow, F., Macpherson, P., Bignami, M., Casorelli, I., Leone, G. G. M., Pagano, L., Sica, S., Halil, O., et al. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0182 · Cited by 25
Cited by
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
“The tumor-suppressing functions of these MMPs is probably another reason for the failure of broad-spectrum MPIs as anticancer drugs (Lopez-Otin and Matrisian, 2007).”
BackgroundThe Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
Cabral-Pacheco, G. A., Garza-Veloz, I., Castruita-De la Rosa, C., Ramirez-Acuña, J. M., Perez-Romero, B. A., Guerrero-Rodriguez, J. F., Martinez-Avila, N., & Martinez-Fierro, M. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249739 · Cited by 1,820
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Gialeli, C., Theocharis, A. D., & Karamanos, N. K. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07919.x · Cited by 1,607
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Metadata
- Authors
- López-Otín, C., & Matrisian, L. M.
- Venue
- Nature Reviews Cancer
- Published
- 2007-10
- Volume
- 7
- Issue
- 10
- Pages
- 800-808
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2028768078
- Cited by
- 802
- References
- 96
- FWCI
- 3.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.